Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.

[1]  Reza Ghadimi,et al.  Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study. , 2019, Bioorganic chemistry.

[2]  B. Larijani,et al.  Design, synthesis, docking study, α-glucosidase inhibition, and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. , 2018, Bioorganic chemistry.

[3]  B. Larijani,et al.  New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study. , 2018, European journal of medicinal chemistry.

[4]  S. N. Bukhari,et al.  Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities. , 2018, European journal of medicinal chemistry.

[5]  B. Larijani,et al.  Synthesis of New Benzimidazole‐1,2,3‐triazole Hybrids as Tyrosinase Inhibitors , 2018, Chemistry & biodiversity.

[6]  B. Kaith,et al.  Indium‐Mediated Domino Allylation‐Lactonisation Approach: Diastereoselective Synthesis of β‐Carboline C‐3 Tethered α‐Methylene γ‐Butyrolactones , 2018 .

[7]  B. Larijani,et al.  Design, synthesis and in vitro α-glucosidase inhibition of novel dihydropyrano[3,2-c]quinoline derivatives as potential anti-diabetic agents. , 2018, Bioorganic chemistry.

[8]  M. Choudhary,et al.  New carbazole linked 1,2,3-triazoles as highly potent non-sugar α-glucosidase inhibitors. , 2017, Bioorganic chemistry.

[9]  Md. Ashraf,et al.  In search of new α-glucosidase inhibitors: Imidazolylpyrazole derivatives. , 2017, Bioorganic chemistry.

[10]  A. Shafiee,et al.  A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease. , 2017, European journal of medicinal chemistry.

[11]  Usman Ghani.  Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. , 2015, European journal of medicinal chemistry.

[12]  M. Bajda,et al.  Organocatalyzed solvent free an efficient novel synthesis of 2,4,5-trisubstituted imidazoles for α-glucosidase inhibition to treat diabetes. , 2015, Bioorganic chemistry.

[13]  A. Shafiee,et al.  Imidazo[2,1-b]thiazole derivatives as new inhibitors of 15-lipoxygenase. , 2014, European journal of medicinal chemistry.

[14]  Cheng‐He Zhou,et al.  Synthesis, antibacterial and antifungal activities of some carbazole derivatives. , 2010, Bioorganic & medicinal chemistry letters.

[15]  A. Gaikwad,et al.  Synthesis and antitubercular screening of imidazole derivatives. , 2009, European journal of medicinal chemistry.

[16]  P. Lou,et al.  A Novel Carbazole Derivative, BMVC: a Potential Antitumor Agent and Fluorescence Marker of Cancer Cells , 2004, Chemistry & biodiversity.

[17]  A. Khalafi‐Nezhad,et al.  Synthesis of N-alkylated derivatives of imidazole as antibacterial agents. , 2003, Bioorganic & medicinal chemistry letters.

[18]  N Zitzmann,et al.  Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Umezawa,et al.  Inhibition of Experimental Metastasis by an α-Glucosidase Inhibitor, 1,6-Epi-cyclophellitol , 1993 .

[20]  J. Groopman.  Current advances in the diagnosis and treatment of AIDS: an introduction. , 1990, Reviews of infectious diseases.